What is Seaport Therapeutics 's market cap?

Seaport Therapeutics (SPTX) has a market capitalization of $972.7M and trades on XNAS.

Where is Seaport Therapeutics headquartered?

Seaport Therapeutics is headquartered in United States of America. It has been publicly traded since 2026.

SPT

Seaport Therapeutics

SPTX

Seaport Therapeutics is a biotechnology company in the healthcare sector trading on XNAS, led by CEO Daphne Zohar, with a market cap of $972.7M.

Market cap

$972.65M+14.6%

Table of contents

Earnings

Q2 2026 report

June 8, 2026

EPS-$10.34Miss by $5.00

Read the full report

Next report

Sep 14, 2026 (in 3 months)

EPS estimate-$0.59

Financials

Q2 2026

Income statement

See full

Operating income-$27.5M-70.2%

Net income-$25.4M-93.6%

EPS (diluted)-$10.34-83.0%

Balance sheet

See full

Cash & equivalents$52.9M—

Total debt$5.3M—

Total equity-$115.6M-220%

Total assets$227.7M—

Cash flow

See full

Operating cash flow-$20.2M+0.2%

CapEx--100%

Free cash flow-$20.2M+0.4%

Valuation & ratios

Valuation

See full

Market cap$972.65M—

Enterprise value$925.08M—

Returns & leverage

See full

Debt / equity-0×—

Current ratio13.2×—

Profile

CountryUnited States of America

Listed2026

CEODaphne Zohar

SectorHealthcare

IndustryBiotechnology

Websiteseaporttx.com

FilingsSEC EDGAR

Questions, answered.

What is Seaport Therapeutics 's market cap?: Seaport Therapeutics (SPTX) has a market capitalization of $972.7M and trades on XNAS.
Where is Seaport Therapeutics headquartered?: Seaport Therapeutics is headquartered in United States of America. It has been publicly traded since 2026.